Home » Authors » James Etheridge

Articles by James Etheridge

Wittycell licenses Technology For Further Vaccine Research

Jan. 10, 2007

By James Etheridge

$65M Raised By Novexel For Anti-infection, Fungal Research

Jan. 10, 2007

By James Etheridge

Wittycell licenses Technology For Further Vaccine Research

Jan. 10, 2007

By James Etheridge

Report from Europe: Cellectis files IPO prospectus on the Paris Stock Exchange

Jan. 5, 2007

By James Etheridge

Cellectis Files IPO Prospectus On The Paris Stock Exchange

Jan. 3, 2007

By James Etheridge

Cellectis Files IPO Prospectus On The Paris Stock Exchange

Jan. 3, 2007

By James Etheridge

Cerep Aims To Cut Losses And End Its Chemistry Arm

Dec. 27, 2006

By James Etheridge

Cerep Aims To Cut Losses And End Its Chemistry Arm

Dec. 27, 2006

By James Etheridge

IntegraGen Setting Up U.S. Subsidiary For Diagnostics

Dec. 20, 2006

By James Etheridge

BioAlliance Gets Green Light For Phase II/III Transdrug Trial

Dec. 20, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...